-
Review
Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
- D J H Mathews, J Sugarman, H Bok, D M Blass, J T Coyle, P Duggan, J Finkel, H T Greely, A Hillis, A Hoke, R Johnson, M Johnston, J Kahn, D Kerr, J Kurtzberg, S M Liao, J W McDonald, G McKhann, K B Nelson, M Rao, A Regenberg, A W Siegel, K Smith, D Solter, H Song, A Vescovi, W Young, J D Gearhart, and R Faden.
- Johns Hopkins University, 100 North Charles Street, Suite 740, Baltimore, MD 21201, USA. dmathews@jhmi.edu
- Neurology. 2008 Jul 22; 71 (4): 288-93.
BackgroundAttempts to translate basic stem cell research into treatments for neurologic diseases and injury are well under way. With a clinical trial for one such treatment approved and in progress in the United States, and additional proposals under review, we must begin to address the ethical issues raised by such early forays into human clinical trials for cell-based interventions for neurologic conditions.MethodsAn interdisciplinary working group composed of experts in neuroscience, cell biology, bioethics, law, and transplantation, along with leading disease researchers, was convened twice over 2 years to identify and deliberate on the scientific and ethical issues raised by the transition from preclinical to clinical research of cell-based interventions for neurologic conditions.ResultsWhile the relevant ethical issues are in many respects standard challenges of human subjects research, they are heightened in complexity by the novelty of the science, the focus on the CNS, and the political climate in which the science is proceeding.ConclusionsDistinctive challenges confronting US scientists, administrators, institutional review boards, stem cell research oversight committees, and others who will need to make decisions about work involving stem cells and their derivatives and evaluate the ethics of early human trials include evaluating the risks, safety, and benefits of these trials, determining and evaluating cell line provenance, and determining inclusion criteria, informed consent, and the ethics of conducting early human trials in the public spotlight. Further study and deliberation by stakeholders is required to move toward professional and institutional policies and practices governing this research.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.